Brief: Cancer Genetics Announces $10.0 Million Private Placement Priced At-The-Market
Jan 28 (Reuters) - Cancer Genetics Inc CGIX.O :
* CANCER GENETICS ANNOUNCES $10.0 MILLION PRIVATE PLACEMENT
PRICED
AT-THE-MARKET
* CANCER GENETICS INC - PRIVATE PLACEMENT PRICED AT A
COMBINED
PURCHASE PRICE OF $3.625 PER SHARE OF COMMON STOCK
Source text for Eikon: ID:nGNX3d9Mpl
Further company coverage: CGIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyant Bio
See all newsBrief: Vyant Bio Provides Update On Winddown Activities
Brief: Vyant Bio Announces Stockholder Approval Of Plan Of Dissolution
Brief: Vyant Bio Files Form 15 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Filing Of Form 25 For Voluntary Nasdaq Delisting And SEC Deregistration
Brief: Vyant Bio Announces Voluntary Nasdaq Delisting, SEC Deregistration